AdvanCell Secures $18M MRFF Grant for Prostate Cancer Therapy

AdvanCell Secures $18M MRFF Grant for Prostate Cancer Therapy AdvanCell, a clinical-stage radiopharmaceutical company pioneering next-generation cancer therapeutics, has been awarded $18 million in funding from the Australian Federal Government through the Medical Research Future Fund (MRFF) Frontiers Initiative. This…










